Business
VOLUNTARY ANNOUNCEMENT APPROVAL FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ON THE NEW DRUG APPLICATION (NDA) OF OUR PIPELINE PRODUCT, CMAB807X (DENOSUMAB INJECTION)
VOLUNTARY ANNOUNCEMENT APPROVAL FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ON THE NEW DRUG APPLICATION (NDA) OF OUR PIPELINE PRODUCT, CMAB807X (DENOSUMAB INJECTION)
About this update from Mabpharm Limited
Mabpharm Limited (2181) Press ReleaseView Attachment